Stomach Cancer Trial, Recruiting NCT05514769 Sponsor: Nanchong Central Hospital Condition: Stomach Cancer
Back to Stomach Cancer

Stomach Cancer Trial, Recruiting

NCT05514769
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with stomach cancer (a type called adenocarcinoma), confirmed by a tissue sample, at stages T1 through T4.
  • People whose general health and ability to carry out daily activities meets a certain minimum level (rated 0 or 1 on a standard medical scale, meaning fully active or able to carry out light activity).
  • People whose liver, kidneys, and other organs are functioning well enough to meet the trial's requirements.

Who may not be able to join:

  • People whose cancer has spread to distant parts of the body (metastasis).
  • People whose cancer has grown into the oesophagus (the tube connecting the throat to the stomach) by more than 3 cm.
  • People whose cancer is classified as a specific aggressive type (Borrmann type 4), or a large tumour of another specific type (Borrmann type 3) measuring more than 8 cm.
  • People who have previously received chemotherapy or radiation treatment for any other cancer.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 12 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nanchong Central Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2021
Est. completion
31 December 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Gastroesophagus reflux disease apprised by ph monitoring; Gastroesophagus reflux disease apprised by questionnaire

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov